Lidocaine ophthalmic Pregnancy and Breastfeeding Warnings

Lidocaine ophthalmic is also known as: Akten

Lidocaine ophthalmic Pregnancy Warnings

Lidocaine has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Lidocaine ophthalmic is only recommended for use during pregnancy when benefit outweighs risk.

See references

Lidocaine ophthalmic Breastfeeding Warnings

Lidocaine is secreted in human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution should be used when lidocaine ophthalmic is administering to nursing women.

See references

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.